Safety of UFT/LV and S-1 as Adjuvant Therapy for Stage III Colon Cancer in Phase III Trial: ACTS-CC Trial

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2012.86
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2017English

P-0218 * Timing and Regimens of Adjuvant Therapy for Resected Stage Ii and Iii Colon Cancer

Annals of Oncology
MedicineOncologyHematology
2014English

Survival Analysis of Adjuvant Chemotherapy With S-1 Plus Cisplatin for Stage III Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2013English

Adjuvant Therapy With Pegylated Interferon Alfa-2b Versus Observation Alone in Resected Stage III Melanoma: Final Results of EORTC 18991, a Randomised Phase III Trial

The Lancet
Medicine
2008English

CTCs as a Prognostic and Predictive Biomarker for Stage II/III Colon Cancer: A Companion Study to the PePiTA Trial

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Factors Associated With Delayed Time to Adjuvant Chemotherapy in Stage Iii Colon Cancer

Current Oncology
Oncology
2014English

Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70

PLoS ONE
Multidisciplinary
2015English

Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
1990English

Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy